QRxPharma refiles Moxduo NDA with FDA

Singapore: Australia-based QRxPharma has resubmitted its Moxduo new drug application (NDA) after the US Food and Drug Ad...

November 26, 2013 | Tuesday | News
Eli Lilly partners with BioNTech to develop cancer immunotherapies

Singapore: Eli Lilly has partnered with German firm, BioNTech, to discover novel cancer immunotherapies through body's o...

May 12, 2015 | Tuesday | News
Boehringer Ingelheim collaborates with Harvard University

Singapore: Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows o...

July 10, 2012 | Tuesday | News
Zydus Cadila launches indigenous diabetes drug

Singapore: Indian pharma company Cadila Healthcare that operates under the aegis of Zydus Group, has launched its patent...

September 20, 2013 | Friday | News
Astellas receives approval of Irribow in Japan

Singapore: Astellas Pharma has obtained the marketing approval of Irribow OD 1 Tablets 2.5µg / 5µg (generic name: ramo...

August 19, 2013 | Monday | News
Biotron to report data from hepatitis C trial

Singapore: Biotron, a clinical-stage drug development company focused on development of new generation antiviral drugs, ...

October 16, 2012 | Tuesday | News
Biocon's novel anti-psoriasis biotech drug Itolizumab released in India

After geting the regulatory approval in early 2013, Biocon, India's number two biotech company by revenues, released the...

August 12, 2013 | Monday | News
Bioventus gets global rights for Pfizer's bone portfolio

Singapore: Bioventus, which specializes in active orthopaedic healing, has acquired exclusive, worldwide license to Pfiz...

July 4, 2013 | Thursday | News
Merck to halt Parkinson's trial due to lack of efficacy

Singapore: Merck, known as Merck Sharp & Dohme (MSD) outside the US and Canada, provided update on its clinical prog...

May 27, 2013 | Monday | News
Hong Kong to host international TCM exhibition, conference

Singapore: Hong Kong Trade Development Council (HKTDC) and Modernized Chinese Medicine International Association (MCMIA ...

August 12, 2013 | Monday | News
Viralytics melanoma trial meets primary endpoint

Singapore: Australia-based biotech company, Viralytics, achieved the primary endpoint in its phase II clinical trial of ...

September 18, 2013 | Wednesday | News
Oramed submits pre-IND to FDA for exenatide

Singapore: Oramed Pharmaceuticals, developer of oral drug delivery systems, submitted a pre-investigational new drug (pr...

September 4, 2013 | Wednesday | Regulatory
GE fortifies iPS cell-derived cellular assay avenue

Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of hum...

December 19, 2012 | Wednesday | News
Daiichi's thrombosis drug meets primary endpoint

Singapore: Global phase III clinical trial of once-daily edoxaban for the treatment of acute symptomatic deep vein throm...

September 2, 2013 | Monday | News
J&J, Pfizer halt phase III trial of Alzheimer's drug

Singapore: Johnson & Johnson (J&J) discontinued phase III clinical development of bapineuzumab intravenous (IV) ...

August 7, 2012 | Tuesday | News
Evotec acquires Sanofi's drug discovery site

Singapore: German firm Evotec has acquired Sanofi's drug discovery operation in Toulouse to build an European centre of ...

December 4, 2014 | Thursday | News
FDA breakthrough for Roche's MS drug

Roche has announced that the US Food and Drug Administration (US FDA) has granted Breakthrough Therapy Designation for t...

February 19, 2016 | Friday | News
Prima BioMed's immunotherapeutic drug secures Japanese patent

May 3, 2016: Australia-based Prima BioMed Ltd has announced that the company has been granted patent number 5908210 enti...

May 3, 2016 | Tuesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls